RhumbLine Advisers Portfolio holdings
AUM
$125B
1-Year Est. Return
27.73%
1 Year Est. Return
+27.73%
AUM
$125B
AUM Growth
+$7.74B
(+6.6%)
Holding
4,268
Top Buys
| 1 | +$125M | |
| 2 | +$75.6M | |
| 3 | +$68.5M | |
| 4 |
TLN
Talen Energy Corp
TLN
|
+$34.1M |
| 5 |
Nutanix
NTNX
|
+$32.6M |
Top Sells
| 1 | +$170M | |
| 2 | +$168M | |
| 3 | +$158M | |
| 4 |
HES
Hess
HES
|
+$72.3M |
| 5 |
ANSS
Ansys
ANSS
|
+$59M |
Sector Composition
| 1 | Technology | 32.91% |
| 2 | Financials | 13.38% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 9.45% |
| 5 | Healthcare | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Burford Capital
BUR
$2.13B
| $3.36M | ﹤0.01% |
280,626
-2,588
|
|
||
1627
Intapp
INTA
$3.14B
| $3.33M | ﹤0.01% |
81,510
-4,131
|
|
||
1628
Vicor
VICR
$6.69B
| $3.33M | ﹤0.01% |
67,022
-2,732
|
|
||
1629
Grab
GRAB
$17.9B
| $3.33M | ﹤0.01% |
553,493
-1,213
|
|
||
1630
Schrodinger
SDGR
$1.24B
| $3.33M | ﹤0.01% |
165,929
-5,418
|
|
||
1631
Amicus Therapeutics
FOLD
$4.43B
| $3.32M | ﹤0.01% |
421,878
-12,474
|
|
||
1632
Dorian LPG
LPG
$1.22B
| $3.32M | ﹤0.01% |
111,313
-24,892
|
|
||
1633
eXp World Holdings
EXPI
$1.52B
| $3.29M | ﹤0.01% |
308,928
+56,120
|
|
||
1634
Cracker Barrel
CBRL
$771M
| $3.29M | ﹤0.01% |
74,572
+1,558
|
|
||
|
TIC
1635
TIC Solutions Inc
TIC
$2.53B
| $3.28M | ﹤0.01% |
246,760
+108,072
|
|
||
1636
Atkore
ATKR
$2.43B
| $3.27M | ﹤0.01% |
52,174
-1,818
|
|
||
1637
Astec Industries
ASTE
$1.12B
| $3.27M | ﹤0.01% |
67,992
-2,446
|
|
||
|
AAT
1638
American Assets Trust
AAT
$1.1B
| $3.27M | ﹤0.01% |
160,912
+8,044
|
|
||
1639
Banco Santander
SAN
$180B
| $3.27M | ﹤0.01% |
311,834
-36,983
|
|
||
1640
Enact Holdings
ACT
$5.63B
| $3.27M | ﹤0.01% |
85,202
+1,469
|
|
||
1641
Harmonic Inc
HLIT
$1.13B
| $3.26M | ﹤0.01% |
320,448
-8,924
|
|
||
1642
CG Oncology
CGON
$4.52B
| $3.25M | ﹤0.01% |
80,758
-1,666
|
|
||
1643
Stepan Co
SCL
$1.17B
| $3.24M | ﹤0.01% |
68,013
-1,725
|
|
||
1644
Worthington Steel
WS
$2.04B
| $3.24M | ﹤0.01% |
106,533
-3,441
|
|
||
1645
James Hardie Industries
JHX
$13.7B
| $3.24M | ﹤0.01% |
168,496
+157,462
|
|
||
1646
Braze
BRZE
$2.58B
| $3.2M | ﹤0.01% |
112,638
+638
|
|
||
1647
Triumph Financial Inc
TFIN
$1.64B
| $3.19M | ﹤0.01% |
63,803
+211
|
|
||
1648
Novo Nordisk
NVO
$277B
| $3.18M | ﹤0.01% |
57,382
-8,174
|
|
||
1649
LGI Homes
LGIH
$1.24B
| $3.18M | ﹤0.01% |
61,558
-3,126
|
|
||
1650
Ultragenyx Pharmaceutical
RARE
$2.17B
| $3.18M | ﹤0.01% |
105,731
+2,105
|
|